Encephalopathy secondary to isoniazid in patients on hemodialysis.
作者信息
Abbas M T, Khan F Y, Sulimon S, Baidaa A
机构信息
Department of Medicine, Hamad General Hospital, Doha, Qatar.
出版信息
Indian J Nephrol. 2013 Jan;23(1):54-6. doi: 10.4103/0971-4065.107206.
Abstract
We report isoniazid (INH)-induced encephalopathy in two male patients on hemodialysis. One of them had tuberculous adenitis, and the other had pulmonary tuberculosis. Both were given rifampicin, INH, pyrazinamide, and ethambutol with pyridoxine 40 mg/day. Two patients developed disturbances in consciousness. After excluding other causes, INH-induced encephalopathy was suspected so the drug was stopped and dose of pyridoxine increased. Both patients retained their consciousness within 1 week and were discharged.
摘要
相似文献
1
Encephalopathy secondary to isoniazid in patients on hemodialysis.
Indian J Nephrol. 2013 Jan;23(1):54-6. doi: 10.4103/0971-4065.107206.
2
API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
J Assoc Physicians India. 2006 Mar;54:219-34.
3
The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.
Am J Respir Crit Care Med. 1999 May;159(5 Pt 1):1580-4. doi: 10.1164/ajrccm.159.5.9810034.
4
5
Outcomes of pulmonary tuberculosis in patients with discordant phenotypic isoniazid resistance testing.
Respir Med. 2017 Dec;133:6-11. doi: 10.1016/j.rmed.2017.11.004. Epub 2017 Nov 8.
6
Isoniazid-induced neuropathy in a pre-pubertal child.
Paediatr Int Child Health. 2019 Aug;39(3):216-218. doi: 10.1080/20469047.2018.1482996. Epub 2018 Jun 13.
7
Encephalopathy caused by isoniazid in a patient with end stage renal disease with extrapulmonary tuberculosis.
Ren Fail. 2003 Jan;25(1):135-8. doi: 10.1081/jdi-120017476.
8
A case of isoniazid-resistant miliary tuberculosis in which tuberculous meningitis paradoxically developed despite systemic improvement.
J Infect Chemother. 2011 Oct;17(5):689-93. doi: 10.1007/s10156-011-0218-1. Epub 2011 Feb 15.
9
Improved Stability of Tuberculosis Drug Fixed-Dose Combination Using Isoniazid-Caffeic Acid and Vanillic Acid Cocrystal.
J Pharm Sci. 2018 Jun;107(6):1667-1679. doi: 10.1016/j.xphs.2018.02.014. Epub 2018 Feb 17.
10
Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
Int J Tuberc Lung Dis. 2016 May;20(5):666-72. doi: 10.5588/ijtld.15.0288.
引用本文的文献
1
Tolerability and Healthcare Utilization in Maintenance Hemodialysis Patients Undergoing Treatment for Tuberculosis-Related Conditions.
Nephron. 2016;132(3):198-206. doi: 10.1159/000444148. Epub 2016 Feb 10.
2
An unusual case of isoniazid toxicity.
Neurol Sci. 2015 Jun;36(6):1037-9. doi: 10.1007/s10072-015-2105-5. Epub 2015 Feb 11.
本文引用的文献
1
Tuberculosis and chronic renal disease.
Semin Dial. 2003 Jan-Feb;16(1):38-44. doi: 10.1046/j.1525-139x.2003.03010.x.
2
Is isoniazid ototoxic in patients undergoing hemodialysis?
Nephron. 2002 Oct;92(2):478-80. doi: 10.1159/000063306.
3
Side-effects of antituberculosis drug treatment in patients with chronic renal failure.
Eur Respir J. 2002 Aug;20(2):440-3. doi: 10.1183/09031936.02.00298002.
4
Increased incidence of tuberculosis in patients undergoing hemodialysis.
Nephron. 1996;73(3):421-4. doi: 10.1159/000189104.
5
Isoniazid induced encephalopathy in dialysis patients.
Tuber Lung Dis. 1993 Apr;74(2):136-9. doi: 10.1016/0962-8479(93)90042-V.
6
Isoniazid-induced neurotoxicity in chronic dialysis patients: report of three cases and a review of the literature.
Nephron. 1993;64(2):303-6. doi: 10.1159/000187331.
7
Decreased acetylation of isoniazid in chronic renal failure.
Clin Pharmacol Ther. 1993 Dec;54(6):612-20. doi: 10.1038/clpt.1993.198.
8
Isoniazid: a review with emphasis on adverse effects.
Chest. 1972 Jul;62(1):71-7. doi: 10.1378/chest.62.1.71.
9
Cerebellar syndrome caused by isoniazid.
DICP. 1990 Sep;24(9):829-31. doi: 10.1177/106002809002400906.
Zotero 插件